A Regional Analysis of Relapsing Remitting MS (RRMS) Patients Treated with Natalizumab Suggests a Need to Diagnose and Treat Early in Latin Americans
Abstract
Authors
P Serafini D Callegaro S Apostolos D Sato E Jones J Pike